ABSTRACT
Background Alcohol use behaviors (AUBs) manifest in a variety of normative and problematic ways across the life course, all of which are heritable. Twin studies show that genetic influences on AUBs change across development, but this is usually not considered in research identifying and investigating the genes linked to AUBs.
Aims Understanding the dynamics of how genes shape AUBs could point to critical periods in which interventions may be most effective and provide insight into the mechanisms behind AUB-related genes. In this project, we investigate how genetic associations with AUBs unfold across development using longitudinal modelling of polygenic scores (PGSs).
Design Using results from genome-wide association studies (GWASs), we created PGSs to index individual-level genetic risk for multiple AUB-related dimensions: Consumption, Problems, a variable pattern of drinking associated with a preference for beer (BeerPref), and externalizing behavior (EXT). We created latent growth curve models and tested PGSs as predictors of latent growth factors (intercept, slope, quadratic) underlying trajectories of AUBs.
Setting PGSs were derived in six longitudinal epidemiological cohorts from the US, UK, and Finland.
Participants Participant data were obtained from AddHealth, ALSPAC, COGA, FinnTwin12, the older Finnish Twin Cohort, and Spit for Science (total N = 19,194). These cohorts included individuals aged 14 to 67, with repeated measures collected over a span of 4 to 36 years.
Measurements Primary measures included monthly frequency of typical alcohol consumption (CON) and heavy episodic drinking (HED).
Findings Results indicated that higher PGSs for all AUBs are robustly associated with higher mean levels of CON and/or HED (B = 0.064-0.333, p < 3.09E-04). However, these same genetic indices were largely not associated with drinking trajectories across cohorts. In the meta-analysis, only PGSs for chronic alcohol Problems consistently predicted a steeper slope (increasing trajectory) of CON across time (B = 0.470, p = 4.20E-06).
Conclusions The results indicate that genetic associations with AUBs not only differ between behaviors, but also across developmental time points and across cohorts. Genetic studies that take such heterogeneity into account are needed to better represent the underlying etiology of AUBs. Individual-level genetic profiles may be useful to point to personalized intervention timelines, particularly for individuals with high alcohol Problems genetic risk scores.
Competing Interest Statement
Dr. Dick is a co-founder of Thrive Genetics, Inc, a member of the advisory board of Seek Health Group, Inc, and owns stock in both companies.
Funding Statement
This research was funded by a grant to J.E.Savage (VI.VENI.201G-064) from The Netherlands Organization for Scientific Research (NWO). Additional support for data analysis was provided by the U.S. National Institute on Drug Abuse grant T32DA55569 (M.C.) and for each study cohort as described below. AddHealth: Add Health is directed by Robert A. Hummer and funded by the National Institute on Aging cooperative agreements U01 AG071448 (Hummer) and U01AG071450 (Aiello and Hummer) at the University of North Carolina at Chapel Hill. Waves I-V data are from the Add Health Program Project, grant P01 HD31921 (Harris) from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), with cooperative funding from 23 other federal agencies and foundations. Add Health was designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill. ALSPAC: We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and Maia Choi and Danielle Dick will serve as guarantors for the contents of this paper. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). Genomewide genotyping data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. COGA: We continue to be inspired by our memories of Henri Begleiter and Theodore Reich, founding PI and Co-PI of COGA, and also owe a debt of gratitude to other past organizers of COGA, including Ting-Kai Li, P. Michael Conneally, Raymond Crowe, and Wendy Reich, for their critical contributions. This national collaborative study is supported by NIH Grant U10AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA). FinnTwin12: FinnTwin12 is supported by the National Institute on Alcohol Abuse and Alcoholism (award numbers R01AA015416, R01AA09203, K02AA018755, and K01AA024152) and the Academy of Finland (grants 100499, 205585, 118555, 141054, 265240, 263278, and 264146). Finnish Twin Cohort: older twins: Phenotype and genotype data collection in the twin cohort has been supported by the Wellcome Trust Sanger Institute, the Broad Institute, ENGAGE - European Network for Genetic and Genomic Epidemiology, FP7-HEALTH-F4-2007, grant agreement number 201413, and the Academy of Finland Center of Excellence in Complex Disease Genetics (grant # 352792). Spit for Science: has been supported by Virginia Commonwealth University, P20AA017828, R37AA011408, K02AA018755, P50AA022537, and K01AA024152 from the National Institute on Alcohol Abuse and Alcoholism, UL1RR031990 from the National Center for Research Resources and National Institutes of Health Roadmap for Medical Research, as well as support by the Center for the Study of Tobacco Products at VCU. REDCap support provided by CTSA award UM1TR004360 from the National Center for Advancing Translational Sciences. We would like to thank Dr. Danielle Dick for founding and directing the Spit for Science Registry from 2011-2022, and the Spit for Science participants for making this study a success, as well as the many University faculty, students, and staff who contributed to the design and implementation of the project. The Externalizing Consortium: Principal Investigators: Danielle M. Dick, Philipp Koellinger, K. Paige Harden, Abraham A. Palmer. Lead Analysts: Richard Karlsson Linner, Travis T. Mallard, Peter B. Barr, Sandra Sanchez-Roige. Significant Contributors: Irwin Waldman. The Externalizing Consortium has been supported by the National Institute on Alcohol Abuse and Alcoholism (R01AA015416 - administrative supplement to DMD), and the National Institute on Drug Abuse (R01DA050721 to DMD). Additional funding for investigator effort has been provided by K02AA018755, U10AA008401, P50AA022537 to DMD, as well as a European Research Council Consolidator Grant (647648 EdGe to Koellinger). The Externalizing Consortium would like to thank the following groups for making the research possible: 23andMe, Add Health, Vanderbilt University Medical Center's BioVU, Collaborative Study on the Genetics of Alcoholism (COGA), the Psychiatric Genomics Consortium's Substance Use Disorders working group, UK10K Consortium, UK Biobank, and Philadelphia Neurodevelopmental Cohort. The content is solely the responsibility of the authors and does not necessarily represent the views of the funding agencies. The funding agencies had no role in the study design, data analysis, manuscript preparation, or decision to submit for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were previously generated and anonymized for use in this study. Raw data from this study are available to qualified researchers. AddHealth: dbGaP accession no. phs001367.v1.p1. ALSPAC: https://www.bristol.ac.uk/alspac/researchers/access/. COGA: https://cogastudy.org/. Finnish Twin Cohort (FinnTwin12 and older cohort): Data used in the analysis is deposited in the Biobank of the Finnish Institute for Health and Welfare (https://thl.fi/en/web/thl-biobank/forresearchers) and is available to researchers after written application and following the relevant Finnish legislation. Spit for Science: dbGaP accession no. phs001754.v4.p2.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
Raw data from this study are available to qualified researchers. AddHealth: dbGaP accession no. phs001367.v1.p1. ALSPAC: https://www.bristol.ac.uk/alspac/researchers/access/. COGA: https://cogastudy.org/. Finnish Twin Cohort (FinnTwin12 and older cohort): Data used in the analysis is deposited in the Biobank of the Finnish Institute for Health and Welfare (https://thl.fi/en/web/thl-biobank/forresearchers) and is available to researchers after written application and following the relevant Finnish legislation. Spit for Science: dbGaP accession no. phs001754.v4.p2.
